RxDoctor Payments Data

Lacie McAbee

Psychiatric/Mental Health · Senatobia, MSNPI 1235582438

Payments from drug & device makers

$681in general payments, 2019–2025

Across 39 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$119
  • Johnson & Johnson$92
  • AbbVie$75
  • Supernus Pharmaceuticals, Inc.$67
  • Teva Pharmaceuticals USA, Inc.$59
  • Lundbeck LLC$58
  • plus $210 from 8 others

What the payments were for

  • Food & beverage$681100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$681 in reported general payments places this provider in the 50th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi

Medicare billing

Part B allowed, 2024
$20,571
Medicare patients
35
Services billed
281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl14$18,323
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine14$2,064
Desvenlafaxine Succinate ErDesvenlafaxine Succinate23$1,770
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine25$1,313
Bupropion XlBupropion Hcl47$808
Lamotrigine41$692
Quetiapine Fumarate22$552
Trazodone Hcl34$410
Buspirone Hcl26$400
Mirtazapine20$379
Olanzapine20$325
Propranolol Hcl22$230
Fluoxetine Hcl34$225
Triamcinolone Acetonide11$222
Diazepam12$183

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$75$18,32314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 486 psychiatric/mental health providers in Mississippi.

Other psychiatric/mental health in Senatobia

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →